Similar articles for PMID: 31983090

Year	Number of Results
1995	1
2001	1
2003	1
2004	1
2005	1
2006	1
2008	5
2009	1
2010	2
2011	1
2013	4
2014	6
2015	11
2016	13
2017	13
2018	11
2019	16
2021	1
2024	0

1

Efficacy and prognosis analysis of surgical treatment for bilateral synchronous multiple primary non-small cell lung cancer.

Chen H, Fu Q, Sun K. Chen H, et al. J BUON. 2019 Nov-Dec;24(6):2245-2252. J BUON. 2019. PMID: 31983090 Free article.

2

Current and future targets and therapies in metastatic colorectal cancer.

Dzunic M, Petkovic I, Cvetanovic A, Vrbic S, Pejcic I. Dzunic M, et al. J BUON. 2019 Sep-Oct;24(5):1785-1792. J BUON. 2019. PMID: 31786838 Free article. Review.

3

Therapeutic Strategies in Diseases of the Digestive Tract - 2015 and Beyond Targeted Therapies in Colon Cancer Today and Tomorrow.

Pohl M, Schmiegel W. Pohl M, et al. Dig Dis. 2016;34(5):574-9. doi: 10.1159/000445267. Epub 2016 Jun 22. Dig Dis. 2016. PMID: 27332557

4

Outcomes for Metastatic Colorectal Cancer Based on Microsatellite Instability: Results from the South Australian Metastatic Colorectal Cancer Registry.

Chong LC, Townsend AR, Young J, Roy A, Piantadosi C, Hardingham JE, Roder D, Karapetis C, Padbury R, Maddern G, Moore J, Price TJ. Chong LC, et al. Target Oncol. 2019 Feb;14(1):85-91. doi: 10.1007/s11523-018-0615-9. Target Oncol. 2019. PMID: 30659494

5

Assessment of somatic k-RAS mutations as a mechanism associated with resistance to EGFR-targeted agents: a systematic review and meta-analysis of studies in advanced non-small-cell lung cancer and metastatic colorectal cancer.

Linardou H, Dahabreh IJ, Kanaloupiti D, Siannis F, Bafaloukos D, Kosmidis P, Papadimitriou CA, Murray S. Linardou H, et al. Lancet Oncol. 2008 Oct;9(10):962-72. doi: 10.1016/S1470-2045(08)70206-7. Epub 2008 Sep 17. Lancet Oncol. 2008. PMID: 18804418 Review.

6

Neuroendocrine Differentiation, Microsatellite Instability, and Tumor-infiltrating Lymphocytes in Advanced Colorectal Cancer With BRAF Mutation.

Digiacomo N, Bolzacchini E, Veronesi G, Cerutti R, Sahnane N, Pinotti G, Bregni M, Artale S, Verusio C, Crivelli F, Capella C, Sessa F, Furlan D. Digiacomo N, et al. Clin Colorectal Cancer. 2019 Jun;18(2):e251-e260. doi: 10.1016/j.clcc.2018.12.003. Epub 2018 Dec 20. Clin Colorectal Cancer. 2019. PMID: 30638691

7

Current synthetic pharmacotherapy for treatment-resistant colorectal cancer: when urgent action is required.

Eng C, Rogers JE. Eng C, et al. Expert Opin Pharmacother. 2019 Apr;20(5):523-534. doi: 10.1080/14656566.2018.1561866. Epub 2019 Jan 8. Expert Opin Pharmacother. 2019. PMID: 30590946 Review.

8

Clinical Utility of Analyzing Circulating Tumor DNA in Patients with Metastatic Colorectal Cancer.

Nakamura Y, Yoshino T. Nakamura Y, et al. Oncologist. 2018 Nov;23(11):1310-1318. doi: 10.1634/theoncologist.2017-0621. Epub 2018 Apr 26. Oncologist. 2018. PMID: 29700206 Free PMC article. Review.

9

Targeted therapy for the treatment of advanced non-small cell lung cancer: a review of the epidermal growth factor receptor antagonists.

Silvestri GA, Rivera MP. Silvestri GA, et al. Chest. 2005 Dec;128(6):3975-84. doi: 10.1378/chest.128.6.3975. Chest. 2005. PMID: 16354869 Review.

10

Targeting BRAF-Mutant Non-Small Cell Lung Cancer: From Molecular Profiling to Rationally Designed Therapy.

Baik CS, Myall NJ, Wakelee HA. Baik CS, et al. Oncologist. 2017 Jul;22(7):786-796. doi: 10.1634/theoncologist.2016-0458. Epub 2017 May 9. Oncologist. 2017. PMID: 28487464 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

75 results

Results by year